Tag: BCMA-CD19 dual-target CAR-T

Home / BCMA-CD19 dual-target CAR-T

Categories

FasTCAR-T GC012F demonstrated overall 100% response rate in newly diagnosed multiple myeloma

Introduction Even in transplant-eligible (TE) patients, typical first-line treatments for high-risk (HR) newly-diagnosed multiple myeloma (NDMM) have dismal outcomes. A high-efficacy, safe CAR-T trea...
bcma-cd19-dual-target-car-t

Scan the code